Alzheimer's disease, a progressive neurodegenerative disorder, poses a significant global health challenge. It primarily affects older adults, with the risk increasing with age. Globally, an estimated 50 million people were living with dementia in 2021, with Alzheimer's disease comprising 60-70% of cases. This prevalence is expected to rise as populations age, potentially reaching 152 million by 2050. Geographically, prevalence rates vary, with higher incidences observed in developed regions due to longer life expectancies and improved diagnostic capabilities. In the United States alone, over 6 million people aged 65 and older are living with Alzheimer's. Understanding these epidemiological trends is crucial for healthcare planning, resource allocation, and advancing research efforts aimed at prevention and treatment.
Title : Cerebral vascular calcium signaling in diabetic alzheimer's disease-related dementias
Yong Xiao Wang, Albany Medical College, United States
Title : Deep learning-based risk assessment of cognitive impairment using health examination data
Kaoru Sakatani, The University of Tokyo, Japan
Title : Evaluation of the neuroprotective potential of indicaxanthin from opuntia ficus indica fruit against dysmetabolism-related neurodegeneration both in vivo and in vitro
Mario Allegra, University of Palermo, Italy
Title : Cogs Club: Making a difference
Jacqueline Tuppen, Cogs Club, United Kingdom
Title : Development of imaging based biomarkers for neurovascular abnormalities in neurodegenerative diseases
Jun Hua, Johns Hopkins University School of Medicine, United States
Title : Psychosocial considerations in management of corticobasal degeneration
Esraa Askar, Forest Hills Hospital, United States